Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Joe Krupa who wrote (7638)	8/21/2001 3:36:44 PM
From: Cal Gary	Read Replies (1) \| Respond to of 14101

Joe, Traditionally, as you know, startup Biotechs stock price moves on FA and news . Given the recent events with DMX and other startup Biotechs, I'd say DMX as it relates to a timeline, have switched positions and will be delivering results ahead of HML and BRA. A head in the races, if there was a race. For the past couple of years, BRA and HML held a large premium market cap than DMX based on anticipated results and timeline. Now if only DMX can get the premium market cap and price. Did anyone notice ANP's openning gap up this morning. $10 bucks.